| Mepha Pharma AG - Teriflunomid-Mepha 14 mg QOD, Filmtabletten | | 68744 | | 02 | | Teriflunomid-Mepha 14 mg QOD | | Filmtabletten | | L04AA31 | | Teriflunomide | | 22.09.2023 | | |
| | Composition | | teriflunomidum 14 mg, lactosum monohydricum 72.25 mg, cellulosum microcristallinum, maydis amylum, carboxymethylamylum natricum A, hydroxypropylcellulosum, silica colloidalis anhydrica, natrii stearylis fumaras, Überzug: hypromellosum, E 171, talcum, macrogolum 8000, E 132, pro compresso obducto corresp. natrium 0.56 mg. | | Packungsbestandteile | | Coated tablets | | | | Active Agent | Dose |
|---|
| Teriflunomidum | 14 mg |
| | | | Inactive agents | Dose | additional_information |
|---|
| Carboxymethylamylum Natricum A | | | | Cellulosum Microcristallinum | | | | E 132 | | color. | | E 171 | | color. | | Hydroxypropylcellulosum | | | | Hypromellosum | | Überzug | | Lactose Monohydrate | 72.25 mg | | | Macrogol | 8000 | | | Maydis Amylum | | | | Natrii Stearylis Fumaras | | | | Pro Compresso Obducto | | | | Silica Colloidalis Anhydrica | | | | Talcum | | |
|
| | Package number | Package Size | EFP | CP | Category | SL | Out of trade (MedRef) |
|---|
| 003 | 28 | PR | PR | B | | No |
|
|
